The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

Risk for Hospital Contact With Infection in Patients With Splenectomy

(2013) Reimar W. Thomsen   ANNALS OF INTERNAL MEDICINE

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA

(2010) D. Stockelberg et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Pathophysiological significance of simultaneous measurement of reticulated platelets, large platelets and serum thrombopoietin in non-neoplastic thrombocytopenic disorders

(2010) Ki-Ryang Koh et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Thrombocytopenic Purpura after Measles-Mumps-Rubella Vaccination: A Systematic Review of the Literature and Guidance for Management

(2010) Elpis Mantadakis et al.   JOURNAL OF PEDIATRICS

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)

(2010) T. B. GERNSHEIMER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Toxicities of the Thrombopoietic Growth Factors

(2010) Adam Cuker   SEMINARS IN HEMATOLOGY

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim

(2009) D. J. Kuter et al.   BLOOD

Referral of patients with thrombocytopenia from primary care clinicians to hematologists

(2009) D. R. Terrell et al.   BLOOD

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

(2009) W. Marieke Schoonen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review

(2009) D. M. Arnold et al.   HAEMATOLOGICA

Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura

(2009) Elham Shahgholi et al.   INDIAN JOURNAL OF PEDIATRICS

A Single Dose of Anti-D Immunoglobulin Raises Platelet Count as Efficiently as Intravenous Immunoglobulin in Newly Diagnosed Immune Thrombocytopenic Purpura in Korean Children

(2009) Dong Woo Son et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

(2009) James B Bussel et al.   LANCET

Absence of platelet recovery followingHelicobacter pylorieradication in childhood chronic idiopathic thrombocytopenic purpura: A multi-center randomized controlled trial

(2009) Suporn Treepongkaruna et al.   PEDIATRIC BLOOD & CANCER

Increased Values of Mean Platelet Volume and Platelet Size Deviation Width May Provide a Safe Positive Diagnosis of Idiopathic Thrombocytopenic Purpura

(2008) George Ntaios et al.   ACTA HAEMATOLOGICA

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature

(2008) A. Salama et al.   ANNALS OF HEMATOLOGY

A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura

(2008) Salah Yousef Abbasi et al.   ANNALS OF HEMATOLOGY

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD

Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura

(2008) C. E. Neunert et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

(2008) R. Stasi et al.   BLOOD

Antiphospholipid antibodies in adults with immune thrombocytopenic purpura

(2008) Carole Pierrot-Deseilligny Despujol et al.   BRITISH JOURNAL OF HAEMATOLOGY

Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response

(2008) Emilia Parodi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials

(2008) James N. George et al.   BRITISH JOURNAL OF HAEMATOLOGY

Grades of Recommendation for Antithrombotic Agents

(2008) Gordon H. Guyatt et al.   CHEST

Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results

(2008) Marta Medeot et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Idiopathic thrombocytopenic purpura in elderly patients: A study of 47 cases from a single reference center

(2008) Samira Daou et al.   European Journal of Internal Medicine

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature

(2008) M. Ruggeri et al.   HAEMATOLOGICA

Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura

(2008) Shannon C. Jackson et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET

One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab

(2008) Brigitta U. Mueller et al.   PEDIATRIC BLOOD & CANCER

Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: A multicentered study from Argentina

(2008) Hugo Donato et al.   PEDIATRIC BLOOD & CANCER

Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients

(2007) Joseph E. Spahr et al.   AMERICAN JOURNAL OF HEMATOLOGY

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias

(2007) Aarati Rao et al.   PEDIATRIC BLOOD & CANCER